Relationship Disclosure: Dr Rabins has received personal compensation for legal testimony from Janssen Pharmaceutica. Dr Rabins has received compensation, including stock, stock options, or expense compensation from Senior Bridge. Dr Rabins' compensation and/or research work has been funded, entirely or in part, by a grant to his university by a governmental organization. Drs Black and Rabins are coholders of the copyright on the Alzheimer Disease Related Quality of Life Instrument. Dr Black's compensation and/or research work has been funded, entirely or in part, by a grant to her university by a governmental organization.
Unlabeled Use of Products / Investigational Use Disclosure: Drs Rabins and Black have nothing to disclose.